An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT03523338 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03523338
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.